A large cohort study of 461,382 GLP-1 users found that 12.7% of patients had a new nutritional deficiency diagnosis at just 6 months of therapy
Where semaglutide falls short High-dose tirzepatide (10 to 15 mg) produces weight loss and metabolic effects that exceed what semaglutide can deliver at any approved dose
Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
The main issue has been that simply, we dont have enough safety data about the use of medications like Ozempic, Wegovy & Mounjaro immediately before and during pregnancy
Our latest home study webinar focuses on the regulatory landscape of #GLP1 compounding, including those related to the active pharmaceutical ingredients
When you eat food, GLP-1 hormone is produced in your gut